BALTIMORE, MD — Among heart-failure patients with low left ventricular ejection fraction (LVEF) who received an implantable cardioverter defibrillator (ICD), the EF improved in 40% of patients during ...

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — The consideration of left ventricular ejection fraction when diagnosing or making treatment ...

A novel artificial intelligence (AI) algorithm shows promise for estimating left ventricular ejection function (LVEF) using routinely obtained left coronary artery angiogram videos, a new study ...

Patients with severe aortic stenosis and left ventricular ejection fraction (LVEF) values in what is typically considered the preserved range are actually at increased risk for poor outcomes, ...

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — Reduced left ventricular ejection fraction may be tied to adverse changes in muscle quality among ...

Tempus AI has gained clearance for software that uses artificial intelligence to identify patients who may have the cardiovascular condition of low left ventricular ejection fraction, or LVEF. The ...

This study investigated long-term mortality outcomes following transcatheter aortic valve replacement (TAVR) among patients with a left ventricular ejection fraction (LVEF) below 50% and comorbid ...

(UPDATED) There may be a benefit to early revascularization over medical therapy in patients with severe inducible ischemia on SPECT testing, regardless of their baseline left ventricular ejection ...

Left ventricular ejection fraction (LVEF) that improves substantially with heart failure treatment should be considered as heart failure with recovered ejection fraction (HFrecEF) but still treated, ...

An analysis of the DELIVER trial also revealed an association between dapagliflozin treatment and reduced risk of cardiovascular death among individuals with heart failure with improved ejection ...

Jardiance (empagliflozin; Boehringer Ingelheim and Lilly) The approval was based on data from the phase 3 EMPEROR-Preserved trial. The Food and Drug Administration (FDA) has approved Jardiance ® ...

Current heart failure (HF) guidelines acknowledge the existence of a distinct subgroup of patients with HF and preserved left ventricular ejection fraction (HFpEF) who had a history of reduced left ...